BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26763364)

  • 1. Intraocular Relapse with Hypopyon and Retinal Infiltrates after Chemotherapy and Peripheral Blood Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma.
    Matsuo T; Tanaka T; Ichimura K; Meguri Y
    J Clin Exp Hematop; 2015; 55(3):157-61. PubMed ID: 26763364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
    Kim SJ; Park S; Kang ES; Choi JY; Lim DH; Ko YH; Kim WS
    Ann Hematol; 2015 Jan; 94(1):71-8. PubMed ID: 25082384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologically Proven Intraocular Infiltration With Adult T-Cell Leukemia/Lymphoma: Two New Cases With Either Vitreous Opacity or Aqueous Hypopyon and Literature Review of 16 Cases.
    Matsuo T; Shimizu T; Tanaka T; Yamamoto A; Takasuka H
    J Investig Med High Impact Case Rep; 2020; 8():2324709620966843. PubMed ID: 33078639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
    Kato T; Tanabe J; Kanemoto M; Kobayashi C; Morita S; Karahashi T
    Mod Rheumatol; 2009; 19(6):675-80. PubMed ID: 19609486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
    Miyazaki K; Suzuki R; Oguchi M; Taguchi S; Amaki J; Maeda T; Kubota N; Maruyama D; Terui Y; Sekiguchi N; Takizawa J; Tsukamoto H; Murayama T; Ando T; Matsuoka H; Hasegawa M; Wada H; Sakai R; Kameoka Y; Tsukamoto N; Choi I; Masaki Y; Shimada K; Fukuhara N; Utsumi T; Uoshima N; Kagami Y; Asano N; Ejima Y; Katayama N; Yamaguchi M
    Hematol Oncol; 2022 Oct; 40(4):667-677. PubMed ID: 35142384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of early diagnosis on the prognosis of extranodal NK/T-cell lymphoma with massive lung involvement: a case report.
    Yabushita T; Yoshioka S; Furumiya T; Nakamura M; Yamashita D; Imai Y; Ishikawa T
    BMC Pulm Med; 2019 Feb; 19(1):48. PubMed ID: 30791900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
    Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
    Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
    Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
    Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal natural killer/T-cell lymphoma, nasal-type.
    Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
    Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system extranodal NK/T cell lymphoma, nasal type, with antecedent hemophagocytic syndrome in a child.
    Jiang X; Yin W; Song J; Chen X; Zhao C; Wen F
    Pediatr Dev Pathol; 2014; 17(6):482-6. PubMed ID: 25207703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative efficacy for nasal type extranodal NK/T-cell lymphoma by autologous peripheral blood stem cell transplantation after sequencing chemotherapy and radiotherapy].
    Wang CB; Bai H; Xi R; Pan YZ; Xu SF; Zhang Q; Chen Y; Zhou JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1477-81. PubMed ID: 24370032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary extranodal natural killer/T-cell lymphoma (ENKTL), nasal type: Two case reports and literature review.
    Hu Q; Xu L; Zhang X; Wang J; Zhou Z
    Medicine (Baltimore); 2020 Jun; 99(26):e20822. PubMed ID: 32590768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
    Inoue D; Nagai Y; Takiuchi Y; Nagano S; Arima H; Kimura T; Shimoji S; Mori M; Togami K; Tabata S; Yanagita S; Matsushita A; Nagai K; Maruoka H; Imai Y; Suzuki R; Takahashi T
    Leuk Lymphoma; 2010 Apr; 51(4):720-3. PubMed ID: 20233057
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
    Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
    J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
    Yoon DH; Kim SJ; Jeong SH; Shin DY; Bae SH; Hong J; Park SK; Yhim HY; Yang DH; Lee H; Kang HJ; Lee MH; Eom HS; Kwak JY; Lee JH; Suh C; Kim WS
    Oncotarget; 2016 Dec; 7(51):85584-85591. PubMed ID: 27542213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
    Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
    J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.